AstraZeneca To Invest $150 Million In Russian Plant
First Published Thursday, 17th February 2011 08:42 pm - © 2011 Dow Jones
Dow Jones NEWSWIRES
MOSCOW -(Dow Jones)- AstraZeneca PLC (AZN, AZN.LN) will invest more than $150 million in building a plant in Russia, the Anglo-Swedish drug maker said on its website Thursday.
Production at the plant--to be built in the Kaluga region southwest of Moscow--is set for the spring of 2013, the company said.
The facility will manufacture drugs to treat cancer and other diseases, including those of the heart and digestive system.
By Nadia Popova, Dow Jones Newswires; +7 495 232 91 92;
